Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001144204-12-025083

Options or other derivatives

  • Chief Financial Officer acquired 56,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

May Larry Alan · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-04-26 Grant or award : show line 1 in the form Stock Option (Right to Buy) +56,250 $0.36 2022-04-25 56,520 56,250 D
Loading xslF345X03/v311243_4.xml…